Literature DB >> 12543745

Five year incidence of cataract surgery: the Blue Mountains Eye Study.

J Panchapakesan1, P Mitchell, K Tumuluri, E Rochtchina, S Foran, R G Cumming.   

Abstract

AIMS: To assess the 5 year incidence of cataract surgery in an older population based prospective cohort.
METHODS: 5 Year prospective follow up of the population based Blue Mountains Eye Study (BMES) performed in 1992. The follow up study examined 2335 survivors (75.1%) of the 3654 baseline participants. Baseline and 5 year slit lamp and retroillumination lens photographs were graded for presence of cortical, nuclear, or posterior subcapsular cataract using the Wisconsin cataract grading method and cataract surgery was documented from the history and the clinical examination.
RESULTS: An overall cataract surgery rate of 5.7% in first or both eyes was documented. The incidence was 0.3% in people aged 49-54 years at baseline, 1.7% for ages 55-64 years, 7.9% for ages 65 to 74 years, and 17.4% in people aged 75 years or older. The rate of surgery in first or both eyes was 6.0% in women and 5.2% in men, age adjusted p = 0.66. Bilateral cataract surgery was performed during follow up on 2.7% of participants, while 43.1% of unilateral phakic cases had second eye surgery. Presence of any posterior subcapsular (PSC) cataract, either alone or in combination with other cataract types, was the most likely type of cataract at baseline to be associated with incident cataract surgery. Baseline age was the most important non-ocular variable predicting incident cataract surgery.
CONCLUSIONS: This study has documented age specific rates for 5 year incident cataract surgery in an older community. The finding of relatively similar incidence rates and ocular predictors of cataract surgery to those reported by the Beaver Dam Eye Study, Wisconsin, United States, is of interest, given previous documented similarities between these two populations.

Entities:  

Mesh:

Year:  2003        PMID: 12543745      PMCID: PMC1771515          DOI: 10.1136/bjo.87.2.168

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

1.  Use of inhaled corticosteroids and the risk of cataracts.

Authors:  R G Cumming; P Mitchell; S R Leeder
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

2.  Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; P R Healey
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

3.  Reproducibility of the Wisconsin cataract grading system in the Blue Mountains Eye Study.

Authors:  J Panchapakesan; R G Cumming; P Mitchell
Journal:  Ophthalmic Epidemiol       Date:  1997-09       Impact factor: 1.648

Review 4.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

5.  Prevalence of lens opacities in the Barbados Eye Study.

Authors:  M C Leske; A M Connell; S Y Wu; L Hyman; A Schachat
Journal:  Arch Ophthalmol       Date:  1997-01

6.  Incident cataract surgery: the Beaver Dam eye study.

Authors:  B E Klein; R Klein; S E Moss
Journal:  Ophthalmology       Date:  1997-04       Impact factor: 12.079

7.  Prevalence of cataract in Australia: the Blue Mountains eye study.

Authors:  P Mitchell; R G Cumming; K Attebo; J Panchapakesan
Journal:  Ophthalmology       Date:  1997-04       Impact factor: 12.079

8.  Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1994-11-15       Impact factor: 5.258

9.  Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract.

Authors:  M C Leske; L T Chylack; S Y Wu; E Schoenfeld; Q He; J Friend; J Wolfe
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079

10.  Progression of lens opacities in cataract patients after one year.

Authors:  B V Magno; M B Datiles; M S Lasa
Journal:  Acta Ophthalmol Scand       Date:  1995-02
View more
  7 in total

1.  Increasing incidence of cataract surgery: population-based study.

Authors:  Heidrun E Gollogly; David O Hodge; Jennifer L St Sauver; Jay C Erie
Journal:  J Cataract Refract Surg       Date:  2013-06-29       Impact factor: 3.351

2.  Cataract surgery and subtype in a defined, older population: the SEECAT Project.

Authors:  A Lewis; N Congdon; B Munoz; H Bowie; H Lai; P Chen; S K West
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Glaucoma and Machine Learning: A Call for Increased Diversity in Data.

Authors:  Sayuri Sekimitsu; Nazlee Zebardast
Journal:  Ophthalmol Glaucoma       Date:  2021-04-17

Review 4.  A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australians.

Authors:  Susan G Poole; J Simon Bell; Natali Jokanovic; Carl M Kirkpatrick; Michael J Dooley
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 5.  Changes in Intraocular Straylight and Visual Acuity with Age in Cataracts of Different Morphologies.

Authors:  Sonia Gholami; Nicolaas J Reus; Thomas J T P van den Berg
Journal:  J Ophthalmol       Date:  2017-07-31       Impact factor: 1.909

6.  Incidence and Characteristics of Cataract Surgery in Poland, during 2010-2015.

Authors:  Michał S Nowak; Iwona Grabska-Liberek; Katarzyna Michalska-Małecka; Andrzej Grzybowski; Milena Kozioł; Wojciech Niemczyk; Barbara Więckowska; Jacek P Szaflik
Journal:  Int J Environ Res Public Health       Date:  2018-03-02       Impact factor: 3.390

7.  Impact of cataract on health-related quality of life in a longitudinal Japanese chronic obstructive pulmonary cohort.

Authors:  Hidehiro Irie; Shotaro Chubachi; Minako Sato; Mamoru Sasaki; Naofumi Kameyama; Takashi Inoue; Yoshitaka Oyamada; Hidetoshi Nakamura; Koichiro Asano; Tomoko Betsuyaku
Journal:  Chron Respir Dis       Date:  2017-12-12       Impact factor: 2.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.